Financials WooGene B&G Co., Ltd

Equities

A018620

KR7018620005

Pharmaceuticals

End-of-day quote Korea S.E. 23:00:00 13/06/2024 BST 5-day change 1st Jan Change
1,144 KRW -1.63% Intraday chart for WooGene B&G Co., Ltd -2.80% -6.61%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 34,621 63,614 79,325 60,663 44,486 35,387
Enterprise Value (EV) 1 60,175 75,655 88,805 65,850 39,118 46,334
P/E ratio -5.11 x -4.71 x -36.9 x -26.8 x 53.1 x -29.9 x
Yield - - - - - -
Capitalization / Revenue 1.23 x 1.95 x 2.01 x 1.54 x 1.02 x 0.61 x
EV / Revenue 2.14 x 2.32 x 2.25 x 1.67 x 0.9 x 0.8 x
EV / EBITDA -23.9 x 16.2 x 31.6 x 26.4 x 11.3 x 9.92 x
EV / FCF -14.5 x - -53.6 x -21.6 x -78 x 21.8 x
FCF Yield -6.89% - -1.87% -4.63% -1.28% 4.6%
Price to Book 1.31 x 2.34 x 2.66 x 1.95 x 1.26 x 1.06 x
Nbr of stocks (in thousands) 16,216 25,965 27,591 28,887 28,887 28,887
Reference price 2 2,135 2,450 2,875 2,100 1,540 1,225
Announcement Date 17/12/21 22/03/21 22/03/21 22/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 28,131 32,559 39,524 39,347 43,703 57,919
EBITDA 1 -2,515 4,663 2,807 2,496 3,467 4,668
EBIT 1 -5,066 2,024 663.5 266.7 1,155 713.7
Operating Margin -18.01% 6.22% 1.68% 0.68% 2.64% 1.23%
Earnings before Tax (EBT) 1 -6,632 126.1 -736.6 -395.9 666.5 -1,764
Net income 1 -6,632 -12,786 -2,064 -2,258 849.6 -1,184
Net margin -23.58% -39.27% -5.22% -5.74% 1.94% -2.04%
EPS 2 -418.2 -520.0 -78.00 -78.49 29.00 -40.98
Free Cash Flow 1 -4,144 - -1,657 -3,049 -501.8 2,130
FCF margin -14.73% - -4.19% -7.75% -1.15% 3.68%
FCF Conversion (EBITDA) - - - - - 45.62%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 17/12/21 22/03/21 22/03/21 22/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 25,554 12,041 9,480 5,187 - 10,947
Net Cash position 1 - - - - 5,368 -
Leverage (Debt/EBITDA) -10.16 x 2.582 x 3.377 x 2.079 x - 2.345 x
Free Cash Flow 1 -4,144 - -1,657 -3,049 -502 2,130
ROE (net income / shareholders' equity) -26.8% - -4.61% -2.4% 1.86% -1.73%
ROA (Net income/ Total Assets) -5.25% - 0.51% 0.22% 0.86% 0.42%
Assets 1 126,410 - -404,906 -1,044,071 98,844 -282,814
Book Value Per Share 2 1,635 1,045 1,082 1,078 1,223 1,161
Cash Flow per Share 2 118.0 191.0 328.0 382.0 682.0 471.0
Capex 1 859 2,710 5,269 2,414 503 1,522
Capex / Sales 3.05% 8.32% 13.33% 6.13% 1.15% 2.63%
Announcement Date 17/12/21 22/03/21 22/03/21 22/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A018620 Stock
  4. Financials WooGene B&G Co., Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW